Harvard Bioscience (HBIO) EPS (Basic) Growth (1y) (2011 - 2026)
Harvard Bioscience (HBIO) EPS (Basic) Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.61 Bn | 129.40 Bn | 1.96 Bn | 25.48% |
| 2 | Becton Dickinson | 52.47 Bn | 51.61 Bn | 2.32 Bn | -31.18% |
| 3 | Alcon | 35.80 Bn | 34.45 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.87 Bn | 32.41 Bn | 861.22 Mn | 1.81% |
| 5 | Medline | 28.89 Bn | 26.21 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.07 Bn | 24.63 Bn | 329.20 Mn | 18.95% |
| 7 | Solventum | 15.33 Bn | 14.92 Bn | 1.29 Bn | 4.17% |
| 8 | Cooper Companies | 14.85 Bn | 14.71 Bn | 735.40 Mn | -191.06% |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 37.39% |
| 10 | Harvard Bioscience | 33.72 Mn | 27.22 Mn | 12.63 Mn | -24.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -24.71% |
| Mar 31, 2026 | 93.29% |
| Dec 31, 2025 | -867.74% |
| Sep 30, 2025 | 74.85% |
| Jun 30, 2025 | 23.41% |
| Mar 31, 2025 | -954.59% |
| Dec 31, 2024 | 175.27% |
| Sep 30, 2024 | -278.47% |
| Jun 30, 2024 | -190.90% |
| Mar 31, 2024 | -850.45% |
| Dec 31, 2023 | 72.69% |
| Sep 30, 2023 | 64.51% |
| Jun 30, 2023 | -139.25% |
| Mar 31, 2023 | 108.59% |
| Dec 31, 2022 | -242.61% |
| Sep 30, 2022 | -1,860.46% |
| Jun 30, 2022 | 647.94% |
| Mar 31, 2022 | -898.16% |
| Dec 31, 2021 | 253.73% |
| Sep 30, 2021 | 85.44% |